Outcome of implants placed to retain craniofacial prostheses – A retrospective cohort study with a follow-up of up to 30 years
| Autor: | Jamie Alberga, Iris Eggels, Anita Visser, Baucke van Minnen, Anke Korfage, Arjan Vissink, Gerry Raghoebar |
|---|---|
| Přispěvatelé: | Personalized Healthcare Technology (PHT), Translational Immunology Groningen (TRIGR), Man, Biomaterials and Microbes (MBM), Clinical chemistry |
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
Dental Implants
craniofacial prosthesis REHABILITATION patient satisfaction congenital DESIGNED SURGICAL GUIDES implant survival rate craniofacial implants Treatment Outcome Extraoral implants SURVIVAL Humans Dental Prosthesis Implant-Supported NASAL HEAD Ear External Oral Surgery General Dentistry radiotherapy Follow-Up Studies Orbital Implants Retrospective Studies |
| Zdroj: | Alberga, J, Eggels, I, Visser, A, van Minnen, B, Korfage, A, Vissink, A & Raghoebar, G 2022, ' Outcome of implants placed to retain craniofacial prostheses – A retrospective cohort study with a follow-up of up to 30 years ', Clinical implant dentistry and related research, vol. 24, no. 5, pp. 643-654 . https://doi.org/10.1111/cid.13106 Clinical Implant Dentistry and Related Research, 24(5), 643-654. Wiley Clinical implant dentistry and related research, 24(5), 643-654. Wiley-Blackwell |
| ISSN: | 1523-0899 |
| DOI: | 10.1111/cid.13106 |
| Popis: | OBJECTIVES: To retrospectively assess the treatment outcomes of endosseous implants placed to retain craniofacial prostheses.MATERIAL AND METHODS: Patients with craniofacial defects resulting from congenital disease, trauma, or oncologic treatment had implant retained prostheses placed in the mastoid, orbital, or nasal region and then assessed over a period of up to 30 years. Implant survival rates were calculated with the Kaplan-Meier method. Clinical assessments consisted of scoring skin reactions under the prosthesis and the peri-implant skin reactions. Possible risk factors for implant loss were identified. Patient satisfaction was evaluated using a 10-point VAS-scale.RESULTS: A total of 525 implants placed in 201 patients were included. The median follow up was 71 months (IQR 28-174 months). Implants placed in the mastoid and nasal region showed the highest overall implant survival rates (10-year implant survival rates of 93.7% and 92.5%, respectively), while the orbital implants had the lowest overall survival rate (84.2%). Radiotherapy was a significant risk factor for implant loss (HR 3.14, p CONCLUSION: Implants used to retain craniofacial prostheses have high survival and patient satisfaction rates and can thus be considered as a predictable treatment option. Radiation is the most important risk factor for implant loss. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text